BIOCONBiocon

Wins a 10-year supply contract for Pertuzumab in Brazil

The contract covers supply of Pertuzumab in Brazil over 10 years.

Price, Monday's close₹391.40▼ 1.51%
Last 5 days

What happened

  • Biocon secured a 10-year supply contract for Pertuzumab in Brazil.

Read the source

This is a summary of public news about Biocon, for information only. It is not a recommendation to buy, sell or hold BIOCON.

Biocon in the news before

  1. 21 SEP 2026 · REGULATORYPertuzumab biosimilar gets a positive opinion from Europe's CHMP
All BIOCON news
Next story · 2 of 5RBL Bank · RBLBANKSets up a $1 billion Euro medium-term note programme